Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®

NCT00929071 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

INDIV

Sponsor class

Conditions

Aging
Pain

Interventions

DEVICE: Evolence
DEVICE: Lidocaine
DRUG: topical anesthetic

Sponsor

Weinkle, Susan H., M.D.